Skip to main content
. Author manuscript; available in PMC: 2016 Feb 5.
Published in final edited form as: Clin Gastroenterol Hepatol. 2012 Aug 16;10(11):1284–1290. doi: 10.1016/j.cgh.2012.08.010

Table 4.

Predictors of Overall Survival: Results of Multivariate Analysis

Variables N Median
Survival
(mo,(95%CI))
One Year
Overall
Survival (%)
p
Univariate
Multivariate* Hazard Ratio
(95%CI)
Gender
  Male 157 6.1 (3,9) 41 0.39
  Female 33 4.9 (2,8) 31
Age (years)
  ≤ 60 145 6.3 (2,10) 43 0.02 0.01 1.7 (1,3)
  > 60 45 3.8 (2,6) 27
Race/ethnicity
  White 44 11.4 (3.8,18) 50 0.52
  Black 82 4.7 (3,6) 34
  Hispanic 54 7.7 (3,12) 41
  Asian 10 2.8 (0,11) 38
Insurance
  Yes 162 7.4 (4.2,11) 43 <0.01
  None 28 2.7 (2,4) 14
Etiology of chronic liver disease
  HCV alone 39 4.4 (2.5,6.1) 32 0.18
  HBV alone 13 9.6 (0,25) 46
  Alcohol alone 17 7.7 (3,13) 39
  HCV/Alcohol 99 6.0 (2,10) 42
  HBV/Alcohol 8 23.5 (0,58) 13
  NASH 7 5.3 (1,9) 57
  Other 7 5.3 (3,7) 38
Symptoms
  Present 111 2.8 (2,3) 18
  Absent 79 21.3 (13,29) 67 <0.01 <0.01 2.1 (1,3)
Child-Pugh-Turcotte
  A 68 16.6 (7,26) 57 <0.01 <0.01 1.6 (1,2)
  B 74 4.3 (1,8) 36
  C 48 1.8 (1,3) 17
Number of tumors
  Solitary 83 16.5 (3,30) 57 <0.01
  Multiple 107 3.7 (2,9) 26
BCLC
  A 38 25.7 (25,39) 75 <0.01
  B 16 19.6 (10,29) 68
  C 82 4.5 (3,6) 31
  D 54 1.9 (1,3) 15
Treatment
  Curative 17 NR 88 <0.01 <0.01 2.9 (2,4)
  Locoregional 50 24.6 (20,29) 73
  Systemic 10 5.9 (3,9) 40
  None 113 2.6 (2,3) 16
Screening US one year prior to HCC diagnosis
  Completed 35 12.5 (0,25) 50 0.25
  Not done 155 4.9 (4,6) 37
More than 2 visits to primary care physician within 2 years of HCC diagnosis
  Yes 97 12.1 (6,18) 50 0.01
  No 93 3.3 (2,5) 27
HIV serostatus
  Positive 26 9.6 (1,18) 40 0.85
  Negative 164 5.2 (4,7) 38
*

Results of the multivariate analysis shown only for significant variables.

NR indicates not reached.